Open data on industry payments to healthcare providers reveal potential hidden costs to the public
Open data on industry payments to healthcare providers reveal potential hidden costs to the public
复制标题
DOI：
10.1038/s41467-019-12317-z
复制
发表时间：
2019-09-20
影响因子：
16.6
通讯作者：
Pestilli, Franco
中科院分区：
文献类型：
--
作者：
Mejia, Jorge;Mejia, Amanda;Pestilli, Franco
医疗保健行业参与者向医疗服务提供者支付非研究费用。虽然这些付款可能会造成利益冲突，但它们与总体医疗费用的关系仍然很大程度上未知。在这项研究中，我们将有关提供商行业支付的开放支付数据与有关医疗保健成本的 Medicare 数据联系起来。我们调查了 374,766 家提供商的行业付款和医疗保健成本。我们证明，接受较高金额行业付款的提供商往往会收取较高的药品和医疗费用。具体来说，我们发现行业支付增加 10% 会导致医疗成本增加 1.3%，药品成本增加 1.8%。例如，对于典型的提供商来说，年度行业付款增加 10% 或 25 美元将导致医疗成本增加约 1,100 美元，药品成本增加约 100 美元。此外，支付与医疗费用之间的关联在各州之间存在显着差异，并且与政治倾向相关，在较为保守的州中这种关联更为强烈。
Healthcare industry players make payments to medical providers for non-research expenses. While these payments may pose conflicts of interest, their relationship with overall healthcare costs remains largely unknown. In this study, we linked Open Payments data on providers' industry payments with Medicare data on healthcare costs. We investigated 374,766 providers' industry payments and healthcare costs. We demonstrate that providers receiving higher amounts of industry payments tend to bill higher drug and medical costs. Specifically, we find that a 10% increase in industry payments is associated with 1.3% higher medical and 1.8% higher drug costs. For a typical provider, for example, a 10% or $25 increase in annual industry payments would be associated with approximately $1,100 higher medical costs and $100 higher drug costs. Furthermore, the association between payments and healthcare costs varies markedly across states and correlates with political leaning, being stronger in more conservative states.